T2DM is characterized by excessive hepatic glucose release, central obesity, impaired pancreatic insulin secretion and decreased insulin sensitivity by target cells leading to insulin resistance with chronic and persistent hyperglycemia. The gene discussed is INS; the disease is Hyperglycemia.